Earnings calls

Remus Pharma. concall ledger

Every earnings call for REMUS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

REMUS · 2 transcripts · Healthcare · latest Q2 FY26

Q2 FY26Published 11 Nov 2025Call held 11 Nov 2025

REMUS Q2 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹400 cr+47% YoYConsolidated EBITDA Margin6.75%Consolidated Net Profit₹22 cr+21% YoYConsolidated PAT Margin5.4%

Consolidated Revenue ₹400 cr (+47% YoY); Consolidated EBITDA Margin 6.75%; Consolidated Net Profit (PAT) ₹22 cr (+21% YoY). Consolidated revenue of ₹400 crores, up 47% YoY.

Read full transcript & analysis

Q4 FY25Published 19 May 2025Call held 19 May 2025

REMUS Q4 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹620.36 cr+191% YoYConsolidated EBITDA₹50.67 cr+59% YoYConsolidated Net Profit₹29.07 cr

Consolidated Revenue ₹620 cr (+191% YoY); Consolidated EBITDA ₹51 cr (+59% YoY); Consolidated Net Profit (Remus) ₹29 cr. Consolidated FY25 revenue grew 191% to INR 620.36 crores.

Read full transcript & analysis